LLY

1,066.57

-0.02%↓

JNJ

230.23

-1.85%↓

ABBV

212.63

-1.61%↓

UNH

377.52

-2.74%↓

AZN

187.14

-0.06%↓

LLY

1,066.57

-0.02%↓

JNJ

230.23

-1.85%↓

ABBV

212.63

-1.61%↓

UNH

377.52

-2.74%↓

AZN

187.14

-0.06%↓

LLY

1,066.57

-0.02%↓

JNJ

230.23

-1.85%↓

ABBV

212.63

-1.61%↓

UNH

377.52

-2.74%↓

AZN

187.14

-0.06%↓

LLY

1,066.57

-0.02%↓

JNJ

230.23

-1.85%↓

ABBV

212.63

-1.61%↓

UNH

377.52

-2.74%↓

AZN

187.14

-0.06%↓

LLY

1,066.57

-0.02%↓

JNJ

230.23

-1.85%↓

ABBV

212.63

-1.61%↓

UNH

377.52

-2.74%↓

AZN

187.14

-0.06%↓

Начало・Списък с акции・NeoGenomics Inc

NeoGenomics Inc

Затворен

9.27 0.43

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

8.99

Максимум

9.35

Ключови измерители
By Trading Economics
Приходи	-7.2M -17M
Продажби	-3.5M 187M
EPS	0.01
Марж на печалбата	-9.164
Служители	2,500
EBITDA	-5.8M -567K

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+61.76% upside

Дивиденти
By Dow Jones
Следващи печалби	28.07.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-31M 1.1B
Предишно отваряне	8.84
Предишно затваряне	9.27

NeoGenomics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

22.05.2026 г., 18:09 ч. UTC

Пазарно говорене

Centralized Crypto Lending Slows in 1Q -- Market Talk

22.05.2026 г., 16:54 ч. UTC

Пазарно говорене

Crypto Spot Volumes Fall 14% in April -- Market Talk

22.05.2026 г., 14:53 ч. UTC

Пазарно говорене

USDT Build on Binance May Signal Refreshed Crypto Appetite -- Market Talk

22.05.2026 г., 11:51 ч. UTC

Пазарно говорене

Bitcoin Dented by U.S. Rate-Rise Bets, Iran War Uncertainty -- Market Talk

22.05.2026 г., 07:28 ч. UTC

Пазарно говорене

Bitcoin Falls as Investors Weigh Conflicting Iran War Headlines -- Market Talk

21.05.2026 г., 17:04 ч. UTC

Пазарно говорене

SpaceX Revealed as Top 10 Bitcoin Holder -- Market Talk

21.05.2026 г., 16:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

21.05.2026 г., 16:08 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

21.05.2026 г., 16:08 ч. UTC

Пазарно говорене

Zcash Backtracks After Yesterday's Surge -- Market Talk

21.05.2026 г., 15:39 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

21.05.2026 г., 15:39 ч. UTC

Пазарно говорене

Hyperliquid ETFs Gaining Momentum as Price Soars -- Market Talk

21.05.2026 г., 13:52 ч. UTC

Пазарно говорене

Bitcoin Shows Signs of Repeating 2022 Trading Pattern -- Market Talk

21.05.2026 г., 07:03 ч. UTC

Пазарно говорене

Bitcoin Falls on Iran War Uncertainty, U.S. Rate Rise Bets -- Market Talk

20.05.2026 г., 17:08 ч. UTC

Пазарно говорене

Zcash Benefiting From Investments in 'Production-Grade Privacy' -- Market Talk

20.05.2026 г., 16:20 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

20.05.2026 г., 15:51 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

20.05.2026 г., 15:51 ч. UTC

Пазарно говорене

Zcash Tears Higher in Mostly Positive Day for Crypto -- Market Talk

20.05.2026 г., 15:39 ч. UTC

Пазарно говорене

Bitcoin Support Seen as $76k, Says Bitfinex -- Market Talk

20.05.2026 г., 13:08 ч. UTC

Пазарно говорене

Bitcoin Rangebound as ETF Outflows Continue -- Market Talk

20.05.2026 г., 12:44 ч. UTC

Пазарно говорене

Bitcoin Gains Slightly as U.S. Stock Futures Rise -- Market Talk

20.05.2026 г., 07:25 ч. UTC

Пазарно говорене

Bitcoin Edges Higher But Iran War Uncertainty Limits Gains -- Market Talk

19.05.2026 г., 16:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

19.05.2026 г., 15:54 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

19.05.2026 г., 15:54 ч. UTC

Пазарно говорене

Bitcoin Holders Under Little Pressure to Sell Despite ETF Outflow -- Market Talk

19.05.2026 г., 14:51 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

19.05.2026 г., 14:51 ч. UTC

Пазарно говорене

Ethereum Down From Near-Term High -- Market Talk

19.05.2026 г., 08:26 ч. UTC

Пазарно говорене

Bitcoin Edges Higher as Oil Price, Bond Yields Fall -- Market Talk

19.05.2026 г., 08:26 ч. UTC

Пазарно говорене

Market Talk Roundup: Latest on U.S. Politics

18.05.2026 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

18.05.2026 г., 17:22 ч. UTC

Пазарно говорене

Tokenized Assets Expected to be Over $1T By 2030 -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

NeoGenomics Inc Прогноза

Ценова цел

By TipRanks

61.76% нагоре

12-месечна прогноза

Среден 14.93 USD 61.76%

Висок 25 USD

Нисък 11 USD

Според 10 анализатори от Wall Street, предложили 12-месечна ценова цел за NeoGenomics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

10 ratings

Купи

Задържане

Продай

Според 10 анализатори, дали борсови рейтинги на NeoGenomics Inc през последните 3 месеца.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.